B2B: Five Practice-Changing Advances on the Horizon Summary
The 7th Bench-to-Bedside Uro-Oncology: GU Cancers Triad Meeting, organized in conjunction with the 45th Annual Congress of the Société Internationale d’Urologie, was held on 31 October 2025, in Edinburgh, Scotland, and transmitted live on the SIU@U Congress app [...]
Authors
- A. Bex
- Simon Tanguay (ORCID: https://orcid.org/0000-0001-6947-304X)
- R. Jones
- Kilian M. Gust
- Peter C. Black
Institutions
- University of British Columbia (CA)
- Beatson West of Scotland Cancer Centre (GB)
- Comprehensive Cancer Center Vienna (AT)
- Oncode Institute (NL)
- University College London (GB)
- McGill University (CA)
- Medical University of Vienna (AT)
Publication Details
- Journal
- Société Internationale d’Urologie Journal
- Published
- 2026-02-09
- DOI
- https://doi.org/10.3390/siuj7010001
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Bristol-Myers Squibb
- AstraZeneca
- Novartis Pharma
- Daiichi Sankyo Europe